Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation

Takeshi Saito, Sachiko Seo, Yoshinobu Kanda, Nahoko Shoji, Toshie Ogasawara, Jun Murakami, Ryuji Tanosaki, Kensei Tobinai, Yoichi Takaue, Shin Mineishi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Pneumocystis carinii (P. carinii) is one of the major opportunistic pathogens responsible for hematopoietic stem cell transplantation (HSCT)-related pneumonias. Although trimethoprim-sulfamethoxazol (TMP/SMX) prophylaxis has been shown to prevent almost all P. carinii infections, 1%-2% of patients may still experience this complication. P. carinii pneumonia (PCP) is usually a late complication in patients receiving TMP/SMX prophylaxis, with most cases occurring later than 2 months post-transplant. We report a patient who developed early onset PCP after allogeneic peripheral blood stem cell transplantation (PBSCT) from an HLA-identical sibling donor. On day 12, the patient complained of dyspnea and cough. A chest X ray showed infiltrates in right upper lobe with bilateral pleural effusion. By the findings of Grocott stain on bronchoalveolar lavage fluid obtained on day 14, he was diagnosed as having PCP. Intravenous TMP/SMX failed to improve the lesion. This is the earliest onset PCP in the literature after HSCT despite the prophylactic administration of TMP/SMX before transplant.

Original languageEnglish
Pages (from-to)206-209
Number of pages4
JournalAmerican Journal of Hematology
Volume67
Issue number3
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Peripheral Blood Stem Cell Transplantation
Trimethoprim
Pneumocystis Pneumonia
Hematopoietic Stem Cell Transplantation
Pneumocystis Infections
Transplants
Pneumocystis carinii
Bronchoalveolar Lavage Fluid
Pleural Effusion
Cough
Dyspnea
Siblings
Pneumonia
Coloring Agents
Thorax
X-Rays
Tissue Donors

Keywords

  • Early onset
  • Hematopoietic stem cell transplantation
  • Mutation
  • Pneumocystis carinii pneumonia

ASJC Scopus subject areas

  • Hematology

Cite this

Saito, T., Seo, S., Kanda, Y., Shoji, N., Ogasawara, T., Murakami, J., ... Mineishi, S. (2001). Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation. American Journal of Hematology, 67(3), 206-209. https://doi.org/10.1002/ajh.1109

Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation. / Saito, Takeshi; Seo, Sachiko; Kanda, Yoshinobu; Shoji, Nahoko; Ogasawara, Toshie; Murakami, Jun; Tanosaki, Ryuji; Tobinai, Kensei; Takaue, Yoichi; Mineishi, Shin.

In: American Journal of Hematology, Vol. 67, No. 3, 2001, p. 206-209.

Research output: Contribution to journalArticle

Saito, T, Seo, S, Kanda, Y, Shoji, N, Ogasawara, T, Murakami, J, Tanosaki, R, Tobinai, K, Takaue, Y & Mineishi, S 2001, 'Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation', American Journal of Hematology, vol. 67, no. 3, pp. 206-209. https://doi.org/10.1002/ajh.1109
Saito, Takeshi ; Seo, Sachiko ; Kanda, Yoshinobu ; Shoji, Nahoko ; Ogasawara, Toshie ; Murakami, Jun ; Tanosaki, Ryuji ; Tobinai, Kensei ; Takaue, Yoichi ; Mineishi, Shin. / Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation. In: American Journal of Hematology. 2001 ; Vol. 67, No. 3. pp. 206-209.
@article{5057fff13fe04952a9835eaebe8b8adf,
title = "Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation",
abstract = "Pneumocystis carinii (P. carinii) is one of the major opportunistic pathogens responsible for hematopoietic stem cell transplantation (HSCT)-related pneumonias. Although trimethoprim-sulfamethoxazol (TMP/SMX) prophylaxis has been shown to prevent almost all P. carinii infections, 1{\%}-2{\%} of patients may still experience this complication. P. carinii pneumonia (PCP) is usually a late complication in patients receiving TMP/SMX prophylaxis, with most cases occurring later than 2 months post-transplant. We report a patient who developed early onset PCP after allogeneic peripheral blood stem cell transplantation (PBSCT) from an HLA-identical sibling donor. On day 12, the patient complained of dyspnea and cough. A chest X ray showed infiltrates in right upper lobe with bilateral pleural effusion. By the findings of Grocott stain on bronchoalveolar lavage fluid obtained on day 14, he was diagnosed as having PCP. Intravenous TMP/SMX failed to improve the lesion. This is the earliest onset PCP in the literature after HSCT despite the prophylactic administration of TMP/SMX before transplant.",
keywords = "Early onset, Hematopoietic stem cell transplantation, Mutation, Pneumocystis carinii pneumonia",
author = "Takeshi Saito and Sachiko Seo and Yoshinobu Kanda and Nahoko Shoji and Toshie Ogasawara and Jun Murakami and Ryuji Tanosaki and Kensei Tobinai and Yoichi Takaue and Shin Mineishi",
year = "2001",
doi = "10.1002/ajh.1109",
language = "English",
volume = "67",
pages = "206--209",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation

AU - Saito, Takeshi

AU - Seo, Sachiko

AU - Kanda, Yoshinobu

AU - Shoji, Nahoko

AU - Ogasawara, Toshie

AU - Murakami, Jun

AU - Tanosaki, Ryuji

AU - Tobinai, Kensei

AU - Takaue, Yoichi

AU - Mineishi, Shin

PY - 2001

Y1 - 2001

N2 - Pneumocystis carinii (P. carinii) is one of the major opportunistic pathogens responsible for hematopoietic stem cell transplantation (HSCT)-related pneumonias. Although trimethoprim-sulfamethoxazol (TMP/SMX) prophylaxis has been shown to prevent almost all P. carinii infections, 1%-2% of patients may still experience this complication. P. carinii pneumonia (PCP) is usually a late complication in patients receiving TMP/SMX prophylaxis, with most cases occurring later than 2 months post-transplant. We report a patient who developed early onset PCP after allogeneic peripheral blood stem cell transplantation (PBSCT) from an HLA-identical sibling donor. On day 12, the patient complained of dyspnea and cough. A chest X ray showed infiltrates in right upper lobe with bilateral pleural effusion. By the findings of Grocott stain on bronchoalveolar lavage fluid obtained on day 14, he was diagnosed as having PCP. Intravenous TMP/SMX failed to improve the lesion. This is the earliest onset PCP in the literature after HSCT despite the prophylactic administration of TMP/SMX before transplant.

AB - Pneumocystis carinii (P. carinii) is one of the major opportunistic pathogens responsible for hematopoietic stem cell transplantation (HSCT)-related pneumonias. Although trimethoprim-sulfamethoxazol (TMP/SMX) prophylaxis has been shown to prevent almost all P. carinii infections, 1%-2% of patients may still experience this complication. P. carinii pneumonia (PCP) is usually a late complication in patients receiving TMP/SMX prophylaxis, with most cases occurring later than 2 months post-transplant. We report a patient who developed early onset PCP after allogeneic peripheral blood stem cell transplantation (PBSCT) from an HLA-identical sibling donor. On day 12, the patient complained of dyspnea and cough. A chest X ray showed infiltrates in right upper lobe with bilateral pleural effusion. By the findings of Grocott stain on bronchoalveolar lavage fluid obtained on day 14, he was diagnosed as having PCP. Intravenous TMP/SMX failed to improve the lesion. This is the earliest onset PCP in the literature after HSCT despite the prophylactic administration of TMP/SMX before transplant.

KW - Early onset

KW - Hematopoietic stem cell transplantation

KW - Mutation

KW - Pneumocystis carinii pneumonia

UR - http://www.scopus.com/inward/record.url?scp=0034965413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034965413&partnerID=8YFLogxK

U2 - 10.1002/ajh.1109

DO - 10.1002/ajh.1109

M3 - Article

VL - 67

SP - 206

EP - 209

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 3

ER -